Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

LAG-3 (CD223) Mouse anti-Human, RB780, Clone: T47-530, BD Horizon™

Catalog No. BDB569094 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
100 Tests
25 Tests
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB569094 100 Tests
BDB569095 25 Tests
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. BDB569094 Supplier BD Biosciences Supplier No. 569094
Only null left
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

LAG-3 (CD223) Monoclonal antibody specifically detects LAG-3 (CD223) in Human samples. It is validated for Flow cytometry
TRUSTED_SUSTAINABILITY

Specifications

Antigen LAG-3 (CD223)
Applications Flow Cytometry
Classification Monoclonal
Clone T47-530
Conjugate RB780
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias LAG3; CD223; FDC; Lymphocyte activation gene 3 protein; Protein FDC
Host Species Mouse
Immunogen Human LAG-3 Recombinant Protein
Purification Method Affinity Chromatography
Quantity 100 Tests
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 3902
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions and unreacted dye was removed.
Form Liquid
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.